Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 5, 2025
Medite Cancer Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | 2012 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '18 Sep 30, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 |
Cash & Equivalents | 0.09 | 0.07 | 0.11 | 0.59 | 0.23 | 0.08 | Upgrade
|
Cash & Short-Term Investments | 0.09 | 0.07 | 0.11 | 0.59 | 0.23 | 0.08 | Upgrade
|
Cash Growth | -94.56% | -32.41% | -81.60% | 155.22% | 206.67% | 15.38% | Upgrade
|
Receivables | 0.83 | 0.45 | 1.35 | 1.8 | 1.99 | 1.59 | Upgrade
|
Inventory | 3.75 | 2.4 | 3.81 | 3.08 | 3.42 | 3.95 | Upgrade
|
Prepaid Expenses | 0.43 | 0.12 | 0.08 | 0.19 | 0.15 | 0.49 | Upgrade
|
Restricted Cash | 0.06 | 0.42 | - | - | - | - | Upgrade
|
Total Current Assets | 5.15 | 3.46 | 5.34 | 5.65 | 5.79 | 6.11 | Upgrade
|
Property, Plant & Equipment | 1.55 | 1.78 | 1.56 | 1.94 | 2.09 | 1.87 | Upgrade
|
Goodwill | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | - | Upgrade
|
Other Intangible Assets | 5.86 | 5.86 | 5.86 | 5.86 | 5.86 | - | Upgrade
|
Other Long-Term Assets | 0.43 | 0.2 | 0.15 | 0.27 | 0.25 | 0.19 | Upgrade
|
Total Assets | 17.65 | 15.96 | 17.57 | 18.38 | 18.64 | 8.17 | Upgrade
|
Accounts Payable | 2.47 | 1 | 1.13 | 0.65 | 0.96 | 0.75 | Upgrade
|
Accrued Expenses | 1.1 | 2.06 | 2.01 | 2.24 | 3.13 | 0.18 | Upgrade
|
Short-Term Debt | - | 0.15 | 0.29 | 0.07 | 0.11 | 2.74 | Upgrade
|
Current Portion of Long-Term Debt | 0.95 | 0.38 | 3.9 | 3.06 | 2.56 | - | Upgrade
|
Current Income Taxes Payable | - | - | - | - | - | 0.21 | Upgrade
|
Other Current Liabilities | 0.1 | 0.19 | 0.03 | 0.14 | 0.05 | 0.1 | Upgrade
|
Total Current Liabilities | 4.63 | 3.78 | 7.35 | 6.16 | 6.8 | 3.98 | Upgrade
|
Long-Term Debt | 5.1 | 4.91 | 0.2 | 0.85 | 1.21 | 1.57 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.49 | 1.49 | 2.01 | 2.21 | 2.21 | - | Upgrade
|
Total Liabilities | 11.21 | 10.18 | 9.55 | 9.21 | 10.21 | 5.55 | Upgrade
|
Common Stock | 0.08 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Additional Paid-In Capital | 17.29 | 13.75 | 9.37 | 8.34 | 5.76 | - | Upgrade
|
Retained Earnings | -10.9 | -8.2 | -1.38 | 0.78 | 1.64 | 2.34 | Upgrade
|
Treasury Stock | -0.33 | -0.33 | -0.33 | -0.33 | -0.33 | - | Upgrade
|
Comprehensive Income & Other | -0.67 | -0.44 | -0.62 | -0.61 | -0.15 | 0.27 | Upgrade
|
Total Common Equity | 5.48 | 4.81 | 7.06 | 8.2 | 6.94 | 2.62 | Upgrade
|
Shareholders' Equity | 6.44 | 5.78 | 8.02 | 9.17 | 8.43 | 2.62 | Upgrade
|
Total Liabilities & Equity | 17.65 | 15.96 | 17.57 | 18.38 | 18.64 | 8.17 | Upgrade
|
Total Debt | 6.05 | 5.44 | 4.38 | 3.98 | 3.87 | 4.31 | Upgrade
|
Net Cash (Debt) | -5.96 | -5.37 | -4.27 | -3.39 | -3.64 | -4.24 | Upgrade
|
Net Cash Per Share | -0.12 | -0.20 | -0.20 | -0.17 | -0.20 | -0.29 | Upgrade
|
Filing Date Shares Outstanding | 72.37 | 28.89 | 22.4 | 21.04 | 19.41 | 14.69 | Upgrade
|
Total Common Shares Outstanding | 72.37 | 28.89 | 22.4 | 21.04 | 19.41 | 14.69 | Upgrade
|
Working Capital | 0.53 | -0.32 | -2 | -0.52 | -1.01 | 2.13 | Upgrade
|
Book Value Per Share | 0.08 | 0.17 | 0.32 | 0.39 | 0.36 | 0.18 | Upgrade
|
Tangible Book Value | -5.04 | -5.71 | -3.46 | -2.31 | -3.57 | 2.62 | Upgrade
|
Tangible Book Value Per Share | -0.07 | -0.20 | -0.15 | -0.11 | -0.18 | 0.18 | Upgrade
|
Land | - | 0.23 | 0.2 | 0.21 | 0.23 | 0.24 | Upgrade
|
Buildings | - | 1.27 | 1.12 | 1.16 | 1.29 | 1.35 | Upgrade
|
Machinery | - | 1.92 | 1.57 | 1.57 | 1.01 | 0.77 | Upgrade
|
Construction In Progress | - | 0 | - | 0.23 | 0.56 | 0.39 | Upgrade
|
Order Backlog | - | 1.2 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.